ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,187Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 3001

$1.52M Total Retail Price of All Prescriptions

Rank: 34 out of 3001

729 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 729 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 729 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 16,402 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
HYDROCODONE-ACETAMINOPHEN 1,268 751 S3 1 7
LISINOPRIL 986 740 2 2
OMEPRAZOLE 853 441 3 4
LEVOTHYROXINE SODIUM 588 369 4 3
SIMVASTATIN 556 417 5 1
FUROSEMIDE 518 448 6 6
METFORMIN HCL 480 337 7 9
GABAPENTIN 461 194 8 14
LANTUS 406 307 9 47
WARFARIN SODIUM 384 309 10 12
CITALOPRAM HBR 357 260 11 16
PRAVASTATIN SODIUM 332 213 12 13
CLONIDINE HCL 310 246 13 64
CEPHALEXIN 302 198 14 86
METOPROLOL TARTRATE 296 251 15 8
DONEPEZIL HCL 293 249 16 27
JANUVIA 287 205 17 54
ATORVASTATIN CALCIUM 281 201 18 11
METOPROLOL SUCCINATE 271 233 19 19
TRAZODONE HCL 269 151 20 37
NOVOLOG 267 186 21 94
LISINOPRIL-HYDROCHLOROTHIAZIDE 266 181 22 22
RANITIDINE HCL 263 195 23 41
DOXAZOSIN MESYLATE 258 202 24 90
POTASSIUM CHLORIDE 249 237 25 15
RISPERIDONE 248 152 26 63
AMLODIPINE BESYLATE 243 181 27 5
QUETIAPINE FUMARATE 225 62 28 66
TAMSULOSIN HCL 202 137 29 29
SERTRALINE HCL 186 76 30 20
CIPROFLOXACIN HCL 181 129 31 56
AZITHROMYCIN 177 119 32 36
ZOLPIDEM TARTRATE 176 111 33 24
BENZTROPINE MESYLATE 174 14 R 34 127
FENOFIBRATE 172 90 35 59
TRAMADOL HCL 172 145 35 17
PAROXETINE HCL 169 79 37 60
PREDNISONE 167 128 38 39
POLYETHYLENE GLYCOL 3350 160 128 39 55
DIVALPROEX SODIUM 157 58 40 70
GEMFIBROZIL 149 89 41 117
PROAIR HFA 144 110 42 30
SSD 139 117 43 265
NAMENDA 139 139 43 40
MIRTAZAPINE 137 55 45 44
HYDROCHLOROTHIAZIDE 137 109 45 10
GLYBURIDE-METFORMIN HCL 137 72 R 45 196
ALLOPURINOL 136 111 48 35
ATENOLOL 132 106 49 18
FLUOXETINE HCL 132 44 49 61
NIFEDIPINE ER 131 120 51 154
ALENDRONATE SODIUM 130 98 52 26
GLIPIZIDE 130 117 52 67
HALOPERIDOL 126 0 54 147
LEVETIRACETAM 122 37 55 112
DIOVAN 121 86 56 50
FLUTICASONE PROPIONATE 119 19 57 42
GLYBURIDE 118 99 R 58 62
FLUOCINONIDE 116 31 59 282
PHENYTOIN SODIUM EXTENDED 112 49 60 126
ESCITALOPRAM OXALATE 109 44 61 82
AMOXICILLIN 108 80 62 107
INSULIN SYRINGE 105 59 63 162
TRIAMCINOLONE ACETONIDE 103 78 64 159
NYSTATIN 100 78 65 149
BUSPIRONE HCL 100 65 65 91
ENULOSE 97 19 67 192
HYDRALAZINE HCL 97 75 67 104
CLOPIDOGREL 97 81 67 28
ISOSORBIDE MONONITRATE ER 97 86 67 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 52 71 77
SEROQUEL 91 25 72 146
HUMALOG 91 47 72 207
LAMOTRIGINE 91 25 72 145
GENERLAC 86 30 75 173
BACLOFEN 85 39 76 125
DIVALPROEX SODIUM ER 81 19 77 142
CARBAMAZEPINE 80 33 78 134
FAMOTIDINE 80 59 78 68
KLOR-CON M20 78 40 80 52
ROPINIROLE HCL 78 62 80 88
CARVEDILOL 78 59 80 25
FENTANYL 78 67 S2 80 76
HYDROXYZINE HCL 77 50 R 84 172
DIGOXIN 76 60 85 65
FLUCONAZOLE 75 16 86 194
PLAVIX 74 61 87 46
OLANZAPINE 73 24 88 106
FLUVOXAMINE MALEATE 73 24 88 243
NEXIUM 71 43 90 23
OXYCODONE-ACETAMINOPHEN 69 60 S2 91 32
VENTOLIN HFA 67 37 92 227
SILVER SULFADIAZINE 65 34 93 351
IPRATROPIUM-ALBUTEROL 64 56 94 119
METOCLOPRAMIDE HCL 64 22 94 139
CAPTOPRIL 63 61 96 371
ALPRAZOLAM 63 50 96 98
COMBIVENT 62 28 98 184
LOSARTAN POTASSIUM 60 55 99 21
SANTYL 59 59 100 273
IBUPROFEN 58 0 101 74
MECLIZINE HCL 58 49 101 153
LEVOFLOXACIN 58 27 101 115
MEGESTROL ACETATE 56 28 R 104 200
NAPROXEN 56 44 104 84
MUPIROCIN 56 38 104 180
OXYBUTYNIN CHLORIDE ER 55 47 107 79
DICLOFENAC SODIUM 55 37 107 118
PROPRANOLOL HCL 54 40 109 136
CYMBALTA 54 38 109 53
TRIAMTERENE-HCTZ 53 41 111 48
AMITRIPTYLINE HCL 52 32 R 112 85
OXYBUTYNIN CHLORIDE 52 52 112 120
TIZANIDINE HCL 52 26 112 101
PROMETHAZINE HCL 51 42 R 115 93
CYCLOBENZAPRINE HCL 51 43 R 115 73
PHENYTOIN 50 16 117 286
DILANTIN 50 30 117 225
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.